Persisting with the theme of environmental exposures being associated with CKD - an interesting study linking silica exposure to kidney disease was published recently by Suma Vupputuri of Kaiser Permanente Georgia in Atlanta, GA, USA and colleagues published in Renal Failure (it's available open access). [I suspect that the reason this paper didn't get published in a higher impact journal is that the association between silica and CKD is already known, however this study was larger and better designed].
Approximately 3 million people are exposed to silica for variable periods of time. Silica in commercial use is obtained by processing (such as crushing or milling) from naturally occurring sources and can be found in abrasive cleaners, toothpaste, scouring powder, and metal polish. At least 10% of these workers may have dangerously high exposures (at least 2-10 times the recommended exposure limit).Occupations that are at risk of exposure include, agricultural (e.g. sweet potato transplanting in North Carolina) and industrial workers (e.g., miners, sandblasters, glassmakers, brick and grain workers)
Prior studies have shown that men exposed to silica, particularly in foundries, brick making or sandblasting, are more likely to have ESRD compared to those who were not exposed and that individuals had increase risk of ESRD with increasing levels of silica exposure.
Overall Design
This was a case control study. Cases were hospital patients with newly diagnosed CKD and community controls were selected using random digit dialing and frequency matched by age, gender, race and proximity to the hospital. The study population consisted of hospital patients and community controls, age 30-79 years residing in North Carolina between 1980 and 1982. The four North Carolina medical centers (Duke University Medical Center, North Carolina Memorial Hospital, Charlotte Memorial Hospital and North Carolina Baptist Hospital) with newly diagnosed CKD, identified by review of kidney-related ICD-9 discharge diagnoses.
Silica exposure estimates were assigned by industrial hygiene review of lifetime job history data and weighted for certainty and intensity. Conditional logistic regression was used to estimate the odds ratios (ORs) for CKD conditioned on demographic, lifestyle and clinical variables.
Sample
Six hundred and seven of 709 case patients could be contacted for interview, 554 of whom (91%) participated in the study (78% overall response rate for cases). Among the control participants, 608 of 717 could be contacted and 520 (86%) were interviewed (73% overall response rate for controls).
Key findings
Limitations
Approximately 3 million people are exposed to silica for variable periods of time. Silica in commercial use is obtained by processing (such as crushing or milling) from naturally occurring sources and can be found in abrasive cleaners, toothpaste, scouring powder, and metal polish. At least 10% of these workers may have dangerously high exposures (at least 2-10 times the recommended exposure limit).Occupations that are at risk of exposure include, agricultural (e.g. sweet potato transplanting in North Carolina) and industrial workers (e.g., miners, sandblasters, glassmakers, brick and grain workers)
Prior studies have shown that men exposed to silica, particularly in foundries, brick making or sandblasting, are more likely to have ESRD compared to those who were not exposed and that individuals had increase risk of ESRD with increasing levels of silica exposure.
Overall Design
This was a case control study. Cases were hospital patients with newly diagnosed CKD and community controls were selected using random digit dialing and frequency matched by age, gender, race and proximity to the hospital. The study population consisted of hospital patients and community controls, age 30-79 years residing in North Carolina between 1980 and 1982. The four North Carolina medical centers (Duke University Medical Center, North Carolina Memorial Hospital, Charlotte Memorial Hospital and North Carolina Baptist Hospital) with newly diagnosed CKD, identified by review of kidney-related ICD-9 discharge diagnoses.
Silica exposure estimates were assigned by industrial hygiene review of lifetime job history data and weighted for certainty and intensity. Conditional logistic regression was used to estimate the odds ratios (ORs) for CKD conditioned on demographic, lifestyle and clinical variables.
Sample
Six hundred and seven of 709 case patients could be contacted for interview, 554 of whom (91%) participated in the study (78% overall response rate for cases). Among the control participants, 608 of 717 could be contacted and 520 (86%) were interviewed (73% overall response rate for controls).
Key findings
- Occupational exposure to silica was associated with a 37% increased risk of CKD and appeared to be specifically related to unclassified renal insufficiency, representing earlier stages of diagnosed CKD.
- Cases, however, were more likely than controls to have fewer years of education, have higher BMI, have histories of hypertension and diabetes, use analgesic medications daily, and have proxy respondents.
- Among those with silica exposure, the median duration of silica exposure after weighting for both certainty and intensity was higher in cases than in controls (22.5 vs. 13.0 years).
- The prevalence of occupational exposure to silica was high and more frequent among cases than controls (48.8% vs. 40.3%, respectively).
- Assessment of duration of occupational exposures showed trends of increasing CKD risk with increased duration of silica exposure.
Limitations
- Self reporting of exposure could have introduced bias (recall and information bias).
- Misclassification bias because the exposure was relatively remote.
- The use of proxies (e.g., spouse or caregiver).
Bottom-line
Silica exposure is associated with an increased of CKD. Specific occupations are at high risk. The dose and the duration of silica exposure, as one would expect, are important risk factors

Guangzhou Academy of biological treatment of leukemia drug research for new breakthroughs
ReplyDeleteSmall molecule inhibitor of Bcr-Abl Imatinib has been a great success in the clinical treatment of chronic myeloid leukemia (CML) and other diseases. Bcr-Abl mutations induced drug resistance has become an important issue in today's medical oncology. Second-generation drug Nilotinib and Dasatinib only to overcome the resistance caused by mutations in some genes, and Bcr-AblT315I the highest incidence of drug-resistant mutations invalid. The ponatinib December 2012 to overcome the Bcr-AblT315I resistance has just been approved by the FDA listed, but the P-Loop area mutations on the Bcr-AblE255K / V, etc. ineffective.
Recently, the Chinese Academy of Sciences Guangzhou Institute of Biomedicine and Health, Dr. Ding Ke led the team to successfully design and synthesis of aryl alkynes and triazole benzamide two types of small molecule inhibitors of Bcr-Abl after nearly four years of technical research. Compounds in a variety of kinases, cell and animal models can effectively overcome the problem of resistance the Bcr-AblT315I mutations induced. Which compounds GZD824 can pM IC50 values suppression the Bcr - AblWT and Bcr-AblT315I of resistant mutants kinase activity (respectively 0.34 and 0.68 nm), and the P-loop mutations (E255K / V). Compound in a variety of cell and animal models exhibit excellent anti-tumor activity (IC50 against the CML K562, Ku812 tumor cells 0.2-10nm; for Family the Bcr-AblT315I mutants Ba/F3 cells IC50 approximately 7Nm; in completely inhibit tumor growth the 1.0-20.0mg/kg/day oral dose) the and better safety indicators and excellent pharmacokinetic properties (rat oral bioavailability of approximately 48.7%; vivo half-life T1 / 2 of approximately 8-10 hours). Currently GZD824 have been identified as candidate drugs, the specification of ongoing pre-clinical Evaluation.
Medchemexpress Can provide the above product,its website:www.medchemexpress.com
Tandutinib
KW-2449
Quizartinib
AST 487
Linifanib
Canertinib
Canertinib dihydrochloride
CP-724714 (E-Double bond)
2-Methoxyestradiol
GSK1904529A